AT352883B - Verfahren zur herstellung eines pharmazeutisch aktiven amorphen steryl-beta-d-glucosid-esters bzw. von diesen enthaltenden praeparaten - Google Patents

Verfahren zur herstellung eines pharmazeutisch aktiven amorphen steryl-beta-d-glucosid-esters bzw. von diesen enthaltenden praeparaten

Info

Publication number
AT352883B
AT352883B AT378376A AT378376A AT352883B AT 352883 B AT352883 B AT 352883B AT 378376 A AT378376 A AT 378376A AT 378376 A AT378376 A AT 378376A AT 352883 B AT352883 B AT 352883B
Authority
AT
Austria
Prior art keywords
amorphic
steryl
glucoside
beta
ester
Prior art date
Application number
AT378376A
Other languages
English (en)
Inventor
Sho Inoue
Masanobu Kawamata
Hirokazu Ushimaru
Koichi Nakamichi
Yutaka Takahashi
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13195074&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AT352883(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Application granted granted Critical
Publication of AT352883B publication Critical patent/AT352883B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J17/005—Glycosides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
AT378376A 1975-05-24 1976-05-24 Verfahren zur herstellung eines pharmazeutisch aktiven amorphen steryl-beta-d-glucosid-esters bzw. von diesen enthaltenden praeparaten AT352883B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP50062263A JPS51139613A (en) 1975-05-24 1975-05-24 An absorbable non-crystalline sterol glycoside monopalmitate ester and a method for preparing its pharmaceutical

Publications (1)

Publication Number Publication Date
AT352883B true AT352883B (de) 1979-10-10

Family

ID=13195074

Family Applications (1)

Application Number Title Priority Date Filing Date
AT378376A AT352883B (de) 1975-05-24 1976-05-24 Verfahren zur herstellung eines pharmazeutisch aktiven amorphen steryl-beta-d-glucosid-esters bzw. von diesen enthaltenden praeparaten

Country Status (10)

Country Link
US (1) US4129649A (de)
JP (1) JPS51139613A (de)
AT (1) AT352883B (de)
BE (1) BE841949A (de)
DE (1) DE2621222B2 (de)
DK (1) DK226076A (de)
FR (1) FR2312508A1 (de)
GB (1) GB1489532A (de)
NL (1) NL168522C (de)
SE (2) SE431217B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4260603A (en) * 1979-01-02 1981-04-07 Pegel Karl H Sterol glycoside with activity as prostaglandin synthetase inhibitor
JPS5874619A (ja) * 1981-10-29 1983-05-06 Nippon Shinyaku Co Ltd リポソ−ム及びその製法
US4614796A (en) * 1983-03-25 1986-09-30 Nippon Shinyaku Co., Ltd. Liposome and method of manufacture therefor
KR950703326A (ko) * 1992-10-14 1995-09-20 아만 히데아키 결정상태의 전이방법
US5811547A (en) * 1992-10-14 1998-09-22 Nippon Shinyaju Co., Ltd. Method for inducing crystalline state transition in medicinal substance
EP1613641B1 (de) * 2003-04-02 2009-01-14 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Cholesterol enthaltende verbindungen und deren verwendung als immunogen gegen borellia burgdorferi

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2746957A (en) * 1952-09-23 1956-05-22 Benjamin Clayton Recovery of water soluble inositol compounds and sterol glycosides
US3036060A (en) * 1958-08-25 1962-05-22 Ciba Geigy Corp New organic compound
NL301747A (de) * 1962-12-14
DE1962757C3 (de) * 1969-12-15 1979-11-15 Boehringer Mannheim Gmbh, 6800 Mannheim Evomonosid-Derivate, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel
JPS5119719B2 (de) * 1972-05-11 1976-06-19
JPS5637967B2 (de) * 1973-05-17 1981-09-03
US3881005A (en) * 1973-08-13 1975-04-29 Lilly Co Eli Pharmaceutical dispersible powder of sitosterols and a method for the preparation thereof

Also Published As

Publication number Publication date
SE7605686L (sv) 1976-11-25
SE431217B (sv) 1984-01-23
DK226076A (da) 1976-11-25
US4129649A (en) 1978-12-12
NL168522C (nl) 1983-09-16
JPS5523246B2 (de) 1980-06-21
DE2621222B2 (de) 1980-05-08
GB1489532A (en) 1977-10-19
SE8301230D0 (sv) 1983-03-07
JPS51139613A (en) 1976-12-02
SE8301230L (sv) 1983-03-07
FR2312508B1 (de) 1979-05-04
BE841949A (fr) 1976-09-16
FR2312508A1 (fr) 1976-12-24
NL168522B (nl) 1981-11-16
NL7605146A (nl) 1976-11-26
DE2621222A1 (de) 1976-12-02

Similar Documents

Publication Publication Date Title
DD129788A5 (de) Verfahren zur herstellung von 3',3'',5',5''-tetrachlorphenol-3,4,5,6-tetrabromsulfophthalein bzw.3',3''-dibrom-5',5''-dichlorphenol-3,4,5,6-tetrachlorsulfophthalein
NL186575C (nl) Werkwijze ter bereiding van aminoalkaan-1,1-difosfonzuren, alsmede werkwijze ter bereiding van een farmaceutisch of cosmetisch preparaat.
AT329780B (de) Verfahren zur herstellung von insulin, insulin-analogen und -derivaten
ATA916173A (de) Verfahren zur herstellung von insulin, insulin-analogen und -derivaten
AT343802B (de) Verfahren zur herstellung von derivaten von 4,6-di-0- (aminoglycosyl)-2-deoxystreptaminen
AT333448B (de) Verfahren zur herstellung von insulin, insulin-analogen und -derivaten
DD130036A5 (de) Verfahren zur herstellung von optisch aktiven 11-desoxy-16-aryloxy-omega-tetranorprostaglandinen
ATA751376A (de) Verfahren zur herstellung von 24,25-dihydroxy- cholesterinderivaten
ATA156576A (de) Verfahren zur herstellung von arzneipraparaten
AT352883B (de) Verfahren zur herstellung eines pharmazeutisch aktiven amorphen steryl-beta-d-glucosid-esters bzw. von diesen enthaltenden praeparaten
AT346842B (de) Verfahren zur herstellung von 1,2-benz- isothiazolen
AT344885B (de) Verfahren zur herstellung von 18-arabinosyl-2-n-butyl-3,7,11,15,19,21,23,25,27,37-dekahydroxy-4,16,32,34,36-pentamethyl-tetrakonta-16,32-dien-35-o-lacton-40-guanidiniumsulfat(debrycin) enthaltenden pharmazeutischen praeparaten
AT307802B (de) Verfahren zur Herstellung von gebrauchsfertigen, pestiziden Zubereitungen
DD131561A5 (de) Verfahren zur herstellung von 5-androsten-derivaten
AT350558B (de) Verfahren zur herstellung von 2,4-dioxo- oxazolidinen
CH550205A (de) Verfahren zur herstellung von n-(aminomethyliden)-thiolphosphorsaeureesterimiden.
AT346852B (de) Verfahren zur herstellung von neuen derivaten des 1,2,4-oxadiazin-5-ons
ATA843973A (de) Verfahren zur herstellung von neuen 2,10-dichlor12-methyl-12h-dibenzo- (d,g) (1,3) -dioxocinderivaten
DD128525A5 (de) Verfahren zur herstellung von 1,2,3,4-tetrahydro-4-oxo-(oder-oxy-)-1-naphthylharnstoffen
AT338289B (de) Verfahren zur herstellung von o,o-dimethyl- bzw. o,o-diathyl-o- (2,2-dichlorvinyl) -thionophosphorsaureester
AT330737B (de) Verfahren zur herstellung von n-cyclohexyl-n-methyl-2-amino-3,5-dibrombenzylamin und dessen saureadditionssalzen
AT326650B (de) Verfahren zur herstellung von 2-substituierten 1,3,4-thiadiazol-5-thiolen
AT340581B (de) Verfahren zur herstellung von pharmazeutischen praparaten mit synergistischer, analgetischer wirkung
AT342074B (de) Verfahren zur herstellung von neuen derivaten des 1-hydroxybenzo-2,3,1-diazaborins
ATA193677A (de) Verfahren zur herstellung von neuen optisch aktiven daunosaminylderivaten von anthracyclinonen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee